Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Tumor-Agnostic 3Head & Neck 3Gynecologic 3Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Uterine Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Proflavine × Gynecologic × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02420665 2021-05-28

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
50 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02095847 2015-04-08

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡